Related Experiment Video

Updated: Sep 23, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

823

Roadmap to next-generation cancer vaccines

Yiran Zheng1, Zhiyuan Zhong1

  • 1College of Pharmaceutical Sciences, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, PR China; Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and, Materials Science, Soochow University, Suzhou 215123, PR China.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|May 13, 2022
PubMed

Insights

Next-generation cancer vaccines are advancing rapidly, offering new ways to fight tumors and prevent recurrence. Cutting-edge technologies aim to boost immune responses and reduce side effects for better cancer treatment.

Area of Science:

  • Immunology
  • Biotechnology
  • Oncology

Background:

  • Cancer vaccines are established therapies for reducing tumor burden and preventing relapse.
  • Recent years have seen significant progress in developing next-generation cancer vaccines.
  • These advancements focus on improving immune responses and minimizing side effects.

Purpose of the Study:

  • To highlight cutting-edge technologies for next-generation cancer vaccines.
  • To explore research directions for enhancing vaccine efficacy and reducing side effects.
  • To discuss the synergy of cancer vaccines with other immunotherapies.

Main Methods:

  • Utilizing bottom-up, high-throughput screening for neoantigen and delivery system identification.
  • Employing top-down, knowledge-based strategies for de novo design of delivery platforms.
  • Engineering tissue-targeting specificity for enhanced delivery.
  • Investigating the combination of cancer vaccines with CAR-T and anti-PD-1 therapies.

Main Results:

  • Identification of novel neoantigens and optimal delivery systems.
  • Development of advanced delivery platforms with tissue-targeting capabilities.
  • Demonstrated potential for synergistic effects when combining vaccines with immunotherapies like CAR-T and anti-PD-1.

Conclusions:

  • Next-generation cancer vaccines leverage advanced technologies for robust and durable immune responses.
  • Future research directions include enhancing therapeutic efficacy and reducing systemic side effects.
  • Combining cancer vaccines with existing immunotherapies holds significant promise for improved cancer treatment outcomes.
Keywords:
Cancer vaccineImmunotherapyNanovaccinesNeoantigenTargeted delivery

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.0K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
527
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
681
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K